Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vimal Mehta Insider Profile
25 Followers
Vimal Mehta, CEO & President, Director at Bioxcel Therapeutics, holds 8.59M shares in Bioxcel Therapeutics (Ticker: BTAI).
Vimal Mehta Bioxcel Therapeutics (BTAI)CEO & President, Director
Bioxcel Therapeutics (BTAI)
CEO & President, Director
Ranked #185 out of 98,564 Corporate Insiders
Profitable Transactions
8 out of 9 Profitable Transactions
Average Return
+133.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO & President, Director
Roles that Vimal Mehta holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 19, 2019 - Aug 19, 2020
Return:+374.00%
The most profitable trade made by Vimal Mehta
Vimal Mehta's Trading History
List of latest transactions for each holding click on a transaction to see Vimal Mehta's performance on stock
You May Also Like
Vimal Mehta insider profile FAQ
What is the percentage of profitable transactions made by Vimal Mehta?
The percentage of profitable transactions made by Vimal Mehta is 89%.
What is the average return per transaction made by Vimal Mehta?
The average return per transaction made by Vimal Mehta is 133.10%.
What stocks does Vimal Mehta hold?
Vimal Mehta holds: BTAI stocks.
What was Vimal Mehta’s latest transaction?
Vimal Mehta latest transaction was an Uninformative Sell of $13.80K.
What was Vimal Mehta's most profitable transaction?
Vimal Mehta’s most profitable transaction was an Informative Buy of BTAI stock on August 19, 2019. The return on the trade was 374.00%.
What is Vimal Mehta's role in Bioxcel Therapeutics?
Vimal Mehta's role in Bioxcel Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.